Scotiabank increased its price target for Ventas, Inc., and Raymond James Financial began coverage of the company.
1 report, 1 independent
Updated Sep 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Scotiabank increased its price target for Ventas, Inc., and Raymond James Financial began coverage of the company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ventas, Inc.
real estate investment trust that owns and manages health care facilities
-
Scotiabank
Canadian bank based in Toronto
-
Raymond James Financial
American Investment Bank and Financial Services Firm
-
Raymond James Financial
American Investment Bank and Financial Services Firm
Related events
- Scotiabank boosted its price target on a stock while a company reported its holdings in an SEC filing.
- Scotiabank boosted its target price for the company, while JPMorgan also raised analyst rating targets.
- Scotiabank raised its price target for NET following the company's Q2 results on August 13, 2025.
- Scotiabank raised its price target and Bank of America upgraded its rating on May 27, 2026, with MarketBeat aggregating the data.
- Ventas, Inc. received buy ratings and target price increases from Jefferies Financial Group and Mizuho Securities on July 2, 2026.